Biorestorative Therapies Inc (BRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Sales | 234 | 89 | 35 | 19 | 31 |
| Cost of Goods | 18 | 7 | N/A | N/A | N/A |
| Gross Profit | 215 | 83 | 35 | 19 | 31 |
| Operating Expenses | 2,521 | 2,558 | 4,144 | 3,240 | 3,135 |
| Operating Income | -2,287 | -2,469 | -4,109 | -3,221 | -3,104 |
| Interest Expense | 0 | -176 | -163 | -376 | -62 |
| Other Income | 1,196 | -1,736 | 1,723 | 541 | 7,811 |
| Pre-tax Income | -1,091 | -4,029 | -2,223 | -2,304 | 4,768 |
| Net Income Continuous | -1,091 | -4,029 | -2,223 | -2,304 | 4,768 |
| Net Income | $-1,091 | $-4,029 | $-2,223 | $-2,304 | $4,768 |
| EPS Basic Total Ops | -0.13 | -0.50 | -0.33 | -0.11 | 1.04 |
| EPS Basic Continuous Ops | -0.13 | -0.50 | -0.33 | -0.11 | 1.04 |
| EPS Diluted Total Ops | -0.13 | -0.50 | -0.33 | 0.54 | 0.39 |
| EPS Diluted Continuous Ops | -0.13 | -0.50 | -0.33 | 0.54 | 0.39 |
| EPS Diluted Before Non-Recurring Items | -0.13 | -0.50 | -0.53 | N/A | N/A |
| EBITDA(a) | $-2,239 | $-2,421 | $-4,067 | $-3,178 | $-3,062 |